Trial
NCT05948540
Department of Defense PTSD Adaptive Platform Trial - Intervention C - Daridorexant
Phase IISUSPENDEDOPERATIONALConfidence: HIGH
Sponsor
Global Coalition for Adaptive Research
Collaborators
U.S. Army Medical Research and Development Command; PPD Development, LP; Berry Consultants; Idorsia Pharmaceuticals Ltd.; Cambridge Cognition Ltd; Citeline
Condition
Post Traumatic Stress Disorder
Intervention
Intervention C Daridorexant
Why stopped
The trial has been temporarily suspended due to administrative issues
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-30